Wordt geladen...
Experimental Serotonergic Agents for the Treatment of Schizophrenia
Schizophrenia remains one of the most chronic and highly disabling mental disorder. To date, the pathomechanism of schizophrenia is not fully understood and current treatments are characterized by some limitations. First- and second-generation antipsychotics have shown clinical efficacy in treating...
Bewaard in:
| Gepubliceerd in: | J Exp Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872893/ https://ncbi.nlm.nih.gov/pubmed/33574716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S259317 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|